Contribution of peptides to multiple sclerosis research

被引:8
作者
Alcaro, Maria Claudia [1 ]
Papini, Anna Maria [1 ]
机构
[1] Univ Florence, Lab Peptide & Prot Chem & Biol, Dipartimento Chim Organ, I-50019 Sesto Fiorentino, FI, Italy
关键词
peptide; multiple sclerosis; antigen; epitope; altered peptide ligand;
D O I
10.1002/bip.20498
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Multiple sclerosis (MS) is an autoimmune disease associated with chronic inflammatory demyelination of the central nervous system in genetically susceptible individuals. Because of the disease complexity and heterogencity, its pathogenesis remains unknown despite extensive research efforts. and specific effective treatments have not yet been developed. Peptide-based research has been important in attempts to unravel particular aspects of this complex disease, including the characterization of the the different molecular mechanisms of MS, with the goal of providing useful products for immune-mediated therapies. In fact, in the past decade, peptide-based research has been predominant in research aimed to identity and/or develop target antigens as synthetic probes for specific biomakers as well as innovative immunomodulating therapics. This review presents an overview of the contributions of peptide science to MS research and discusses future directions of peptide-based investigations. (c) 2006 Wiley Periodicals, Inc.
引用
收藏
页码:349 / 367
页数:19
相关论文
共 152 条
  • [1] Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade
    Allen, SD
    Rawale, SV
    Whitacre, CC
    Kaumaya, PTP
    [J]. JOURNAL OF PEPTIDE RESEARCH, 2005, 65 (06): : 591 - 604
  • [2] Multiple MAG peptides are recognized by circulating T and B lymphocytes in polyneuropathy and multiple sclerosis
    Andersson, M
    Yu, M
    Söderström, M
    Weerth, S
    Baig, S
    Linington, C
    Solders, G
    Link, H
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2002, 9 (03) : 243 - 251
  • [3] Anderton SM, 1998, J IMMUNOL, V161, P3357
  • [4] Immunotherapy for multiple sclerosis: From theory to practice
    Antel, JP
    Becher, B
    Owens, T
    [J]. NATURE MEDICINE, 1996, 2 (10) : 1074 - 1075
  • [5] Identification of core structure and critical T cell receptor contact residues in an antigenic peptide by measuring acidification rates
    Arimilli, S
    Deshpande, SV
    Nag, B
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1998, 212 (01) : 49 - 59
  • [6] Cross-reactivity of T-cell clones specific for altered peptide ligands of myelin basic protein
    Ausubel, LJ
    Bieganowska, KD
    Hafler, DA
    [J]. CELLULAR IMMUNOLOGY, 1999, 193 (01) : 99 - 107
  • [7] BASHIR K, 2002, HDB MULTIPLE SCLEROS
  • [8] THE RAPID ISOLATION OF CLONABLE ANTIGEN-SPECIFIC LYMPHOCYTE-T LINES CAPABLE OF MEDIATING AUTOIMMUNE ENCEPHALOMYELITIS
    BENNUN, A
    WEKERLE, H
    COHEN, IR
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (03) : 195 - 199
  • [9] Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event
    Berger, T
    Rubner, P
    Schautzer, F
    Egg, R
    Ulmer, H
    Mayringer, I
    Dilitz, E
    Deisenhammer, F
    Reindl, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (02) : 139 - 145
  • [10] Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand
    Bielekova, B
    Goodwin, B
    Richert, N
    Cortese, I
    Kondo, T
    Afshar, G
    Gran, B
    Eaton, J
    Antel, J
    Frank, JA
    McFarland, HF
    Martin, R
    [J]. NATURE MEDICINE, 2000, 6 (10) : 1167 - 1175